Localization and regulation of pancreatic selenoprotein P

Journal of Molecular Endocrinology

Volumn 50, Issue 1, 2013, Pages 31-42

  Steinbrenner, Holger ^a   Hotze, Anna Lena ^a,b   Speckmann, Bodo ^a   Pinto, Antonio ^a   Sies, Helmut ^a,c   Schott, Matthias ^b   Ehlers, Margret ^b   Scherbaum, Werner A ^b   Schinner, Sven ^b  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^c KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

B cell; Diabetes; Oxidative stress; Pancreatic islet; Selenium; Selenoprotein

Indexed keywords

GLUCOSE; GLUTATHIONE PEROXIDASE 1; SELENATE; SELENIUM; SELENOPROTEIN P; STREPTOZOCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIOXIDANT ACTIVITY; ARTICLE; BIOSYNTHESIS; DOWN REGULATION; INSULINOMA; MOUSE; NONHUMAN; PANCREAS; PANCREAS ISLET ALPHA CELL; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; REGULATORY MECHANISM;

ANIMALS; BLOTTING, WESTERN; CELL LINE, TUMOR; DOWN-REGULATION; FLUORESCENT ANTIBODY TECHNIQUE; GENES, REPORTER; GLUCOSE; ISLETS OF LANGERHANS; MICE; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; SELENOPROTEIN P; STREPTOZOCIN;

EID: 84872049903     PISSN: 09525041     EISSN: 14796813     Source Type: Journal    
DOI: 10.1530/JME-12-0105     Document Type: Article

References (52)

1. Arteel GE, Mostert V, Oubrahim H, Briviba K, Abel J & Sies H 1998 Protection by selenoprotein P in human plasma against peroxynitrite-mediated oxidation and nitration. Biological Chemistry 379 1201-1205.
2. Asfari M, Janjic D, Meda P, Li G, Halban PA & Wollheim CB 1992 Establishment of 2-mercaptoethanol-dependent differentiated insulin-secreting cell lines. Endocrinology 130 167-178. (doi:10.1210/ en.130.1.167)
3. Bast A, Wolf G, Oberbäumer I & Walther R 2002 Oxidative and nitrosative stress induces peroxiredoxins in pancreatic b cells. Diabetologia 45 867-876. (doi:10.1007/s00125-002-0846-1)
4. Bindokas VP, Kuznetsov A, Sreenan S, Polonsky KS, Roe MW & Philipson LH 2003 Visualizing superoxide production in normal and diabetic rat islets of Langerhans. Journal of Biological Chemistry 278 9796-9801. (doi:10.1074/jbc.M206913200)
5. Burk RF & Hill KE 2009 Selenoprotein P-expression, functions, and roles in mammals. Biochimica et Biophysica Acta 1790 1441-1447. (doi:10.1016/ j.bbagen.2009.03.026)
6. Campbell SC, Aldibbiat A, Marriott CE, Landy C, Ali T, Ferris WF, Butler CS, Shaw JA & Macfarlane WM 2008 Selenium stimulates pancreatic b-cell gene expression and enhances islet function. FEBS Letters 582 2333-2337. (doi:10.1016/j.febslet.2008.05.038)
7. Darville MI & Eizirik DL 1998 Regulation by cytokines of the inducible nitric oxide synthase promoter in insulin-producing cells. Diabetologia 41 1101-1108. (doi:10.1007/s001250051036)
8. Donath MY, Størling J, Maedler K & Mandrup-Poulsen T 2003 Inflammatory mediators and islet b-cell failure: a link between type 1 and type 2 diabetes. Journal of Molecular Medicine 81 455-470. (doi:10.1007/ s00109-003-0450-y)
9. Dreher I, Jakobs TC & Köhrle J 1997 Cloning and characterization of the human selenoprotein P promoter. Response of selenoprotein P expression to cytokines in liver cells. Journal of Biological Chemistry 272 29364-29371. (doi:10.1074/jbc.272.46.29364)
10. Drews G, Krippeit-Drews P & Düfer M 2010 Oxidative stress and b-cell dysfunction. Pflügers Archiv 460 703-718. (doi:10.1007/s00424-010-0862-9)
11. Harmon JS, Bogdani M, Parazzoli SD, Mak SS, Oseid EA, Berghmans M, Leboeuf RC & Robertson RP 2009 b-Cell-specific overexpression of glutathione peroxidase preserves intranuclear MafA and reverses diabetes in db/db mice. Endocrinology 150 4855-4862. (doi:10.1210/ en.2009-0708)
12. Hoefig CS, Renko K, Köhrle J, Birringer M & Schomburg L 2011 Comparison of different selenocompounds with respect to nutritional value vs. toxicity using liver cells in culture. Journal of Nutritional Biochemistry 22 945-955. (doi:10.1016/j.jnutbio.2010.08.006)
13. Hoffmann PR, Höge SC, Li PA, Hoffmann FW, Hashimoto AC & Berry MJ 2007 The selenoproteome exhibits widely varying, tissue-specific dependence on selenoprotein P for selenium supply. Nucleic Acids Research 35 3963-3973. (doi:10.1093/nar/gkm355)
14. Hotamisligil GS, Shargill NS & Spiegelman BM 1993 Adipose expression of tumor necrosis factor-a: direct role in obesity-linked insulin resistance. Science 259 87-91. (doi:10.1126/science.7678183)
15. Kahn SE 2003 The relative contributions of insulin resistance and b-cell dysfunction to the pathophysiology of type 2 diabetes. Diabetologia 46 3-19. (doi:10.1007/s00125-003-1190-9)
16. Kim JW & Yoon KH 2011 Glucolipotoxicity in pancreatic b-cells. Diabetes & Metabolism Journal 35 444-450. (doi:10.4093/dmj.2011.35.5.444)
17. Lakey JR, Suarez-Pinzon WL, Strynadka K, Korbutt GS, Rajotte RV, Mabley JG, Szabó C & Rabinovitch A 2001 Peroxynitrite is a mediator of cytokine-induced destruction of human pancreatic islet b cells. Laboratory Investigation 81 1683-1692. (doi:10.1038/labinvest. 3780381)
18. Laybutt DR, Kaneto H, Hasenkamp W, Grey S, Jonas JC, Sgroi DC, Groff A, Ferran C, Bonner-Weir S, Sharma A et al. 2002 Increased expression of antioxidant and antiapoptotic genes in islets that may contribute to b-cell survival during chronic hyperglycemia. Diabetes 51 413-423. (doi:10.2337/diabetes.51.2.413)
19. Lee SR, Yon JM, Baek IJ, Kim MR, Park CG, Lee BJ, Yun YW & Nam SY 2008 Spatiotemporal expression of the selenoprotein P gene in post-implantational mouse embryos. International Journal of Developmental Biology 52 1005-1011. (doi:10.1387/ijdb.082656sl)
20. Lei XG & Vatamaniuk MZ 2011 Two tales of antioxidant enzymes on b cells and diabetes. Antioxidants & Redox Signaling 14 489-503. (doi:10.1089/ ars.2010.3416)
21. Lenzen S 2008 The mechanisms of alloxan- and streptozotocin-induced diabetes. Diabetologia 51 216-226. (doi:10.1007/s00125-007-0886-7)
22. Lu WT, Juang JH, Hsu BR & Huang HS 1998 Effects of high or low dose of streptozocin on pancreatic islets in C57BL/6 and C.B17-SCID mice. Transplantation Proceedings 30 609-610. (doi:10.1016/S0041-1345(97)01425-5)
23. Ma S, Hill KE, Caprioli RM & Burk RF 2002 Mass spectrometric characterization of full-length rat selenoprotein P and three isoforms shortened at the C terminus. Evidence that three UGA codons in the mRNA open reading frame have alternative functions of specifying selenocysteine insertion or translation termination. Journal of Biological Chemistry 277 12749-12754. (doi:10.1074/jbc.M111462200)
24. Maechler P, Jornot L & Wollheim CB 1999 Hydrogen peroxide alters mitochondrial activation and insulin secretion in pancreatic b cells. Journal of Biological Chemistry 274 27905-27913. (doi:10.1074/jbc.274. 39.27905)
25. McClung JP, Roneker CA, Mu W, Lisk DJ, Langlais P, Liu F & Lei XG 2004 Development of insulin resistance and obesity in mice overexpressing cellular glutathione peroxidase. PNAS 101 8852-8857. (doi:10.1073/ pnas.0308096101)
26. Minn AH, Hafele C & Shalev A 2005 Thioredoxin-interacting protein is stimulated by glucose through a carbohydrate response element and induces b-cell apoptosis. Endocrinology 146 2397-2405. (doi:10.1210/ en.2004-1378)
27. Misu H, Takamura T, Takayama H, Hayashi H, Matsuzawa-Nagata N, Kurita S, Ishikura K, Ando H, Takeshita Y, Ota T et al. 2010 A liver-derived secretory protein, selenoprotein P, causes insulin resistance. Cell Metabolism 12 483-495. (doi:10.1016/j.cmet.2010.09.015)
28. Morgan D, Oliveira-Emilio HR, Keane D, Hirata AE, Santos da Rocha M, Bordin S, Curi R, Newsholme P & Carpinelli AR 2007 Glucose, palmitate and pro-inflammatory cytokines modulate production and activity of a phagocyte-like NADPH oxidase in rat pancreatic islets and a clonal b cell line. Diabetologia 50 359-369. (doi:10.1007/s00125-006-0462-6)
29. Nishiyama A, Matsui M, Iwata S, Hirota K, Masutani H, Nakamura H, Takagi Y, Sono H, Gon Y & Yodoi J 1999 Identification of thioredoxin-binding protein-2/vitamin D(3) up-regulated protein 1 as a negative regulator of thioredoxin function and expression. Journal of Biological Chemistry 274 21645-21650. (doi:10.1074/jbc.274.31.21645)
30. Niwa H, Harrison LC, DeAizpurua HJ & Cram DS 1997 Identification of pancreatic b cell-related genes by representational difference analysis. Endocrinology 138 1419-1426. (doi:10.1210/en.138.4.1419)
31. Nukatsuka M, Sakurai H, Yoshimura Y, Nishida M & Kawada J 1988 Enhancement by streptozotocin of O2- radical generation by the xanthine oxidase system of pancreatic b-cells. FEBS Letters 239 295-298. (doi:10.1016/0014-5793(88)80938-4)
32. Pi J, Bai Y, Zhang Q, Wong V, Floering LM, Daniel K, Reece JM, Deeney JT, Andersen ME, Corkey BE et al. 2007 Reactive oxygen species as a signal in glucose-stimulated insulin secretion. Diabetes 56 1783-1791. (doi:10.2337/db06-1601)
33. Poitout V & Robertson RP 2008 Glucolipotoxicity: fuel excess and b-cell dysfunction. Endocrine Reviews 29 351-366. (doi:10.1210/er.2007-0023)
34. Schinner S, Scherbaum WA, Bornstein SR & Barthel A 2005 Molecular mechanisms of insulin resistance. Diabetic Medicine 22 674-682. (doi:10.1111/j.1464-5491.2005.01566.x)
35. Schinner S, Ulgen F, Papewalis C, Schott M, Woelk A, Vidal-Puig A & Scherbaum WA 2008 Regulation of insulin secretion, glucokinase gene transcription and b cell proliferation by adipocyte-derived Wnt signalling molecules. Diabetologia 51 147-154. (doi:10.1007/ s00125-007-0848-0)
36. Sies H 1986 Biochemistry of oxidative stress. Angewandte Chemie International Edition in English 25 1058-1071. (doi:10.1002/anie. 198610581)
37. Speckmann B, Walter PL, Alili L, Reinehr R, Sies H, Klotz LO & Steinbrenner H 2008 Selenoprotein P expression is controlled through interaction of the coactivator PGC-1a with FoxO1a and hepatocyte nuclear factor 4a transcription factors. Hepatology 48 1998-2006. (doi:10.1002/hep.22526)
38. Speckmann B, Sies H & Steinbrenner H 2009 Attenuation of hepatic expression and secretion of selenoprotein P by metformin. Biochemical and Biophysical Research Communications 387 158-163. (doi:10.1016/ j.bbrc.2009.06.143)
39. Speckmann B, Pinto A, Winter M, Förster I, Sies H & Steinbrenner H 2010 Proinflammatory cytokines down-regulate intestinal selenoprotein P biosynthesis via NOS2 induction. Free Radical Biology & Medicine 49 777-785. (doi:10.1016/j.freeradbiomed.2010.05.035)
40. Steinbrenner H & Sies H 2009 Protection against reactive oxygen species by selenoproteins. Biochimica et Biophysica Acta 1790 1478-1485. (doi:10.1016/j.bbagen.2009.02.014)
41. Steinbrenner H, Alili L, Bilgic E, Sies H & Brenneisen P 2006 Involvement of selenoprotein P in protection of human astrocytes from oxidative damage. Free Radical Biology & Medicine 40 1513-1523. (doi:10.1016/ j.freeradbiomed.2005.12.022)
42. Takebe G, Yarimizu J, Saito Y, Hayashi T, Nakamura H, Yodoi J, Nagasawa S & Takahashi K 2002 A comparative study on the hydroperoxide and thiol specificity of the glutathione peroxidase family and selenoprotein P. Journal of Biological Chemistry 277 41254-41258. (doi:10.1074/jbc.M202773200)
43. Takeda Y, Fujita Y, Honjo J, Yanagimachi T, Sakagami H, Takiyama Y, Makino Y, Abiko A, Kieffer TJ & Haneda M 2012 Reduction of both b cell death and a cell proliferation by dipeptidyl peptidase-4 inhibition in a streptozotocin-induced model of diabetes in mice. Diabetologia 55 404-412. (doi:10.1007/s00125-011-2365-4)
44. Tang C, Han P, Oprescu AI, Lee SC, Gyulkhandanyan AV, Chan GN, Wheeler MB & Giacca A 2007 Evidence for a role of superoxide generation in glucose-induced b-cell dysfunction in vivo. Diabetes 56 2722-2731. (doi:10.2337/db07-0279)
45. Tiedge M, Lortz S, Drinkgern J & Lenzen S 1997 Relation between antioxidant enzyme gene expression and antioxidative defense status of insulin-producing cells. Diabetes 46 1733-1742. (doi:10.2337/ diabetes.46.11.1733)
46. Turk J, Corbett JA, Ramanadham S, Bohrer A & McDaniel ML 1993 Biochemical evidence for nitric oxide formation from streptozotocin in isolated pancreatic islets. Biochemical and Biophysical Research Communications 197 1458-1464. (doi:10.1006/bbrc.1993. 2641)
47. Twigger SN, Shimoyama M, Bromberg S, Kwitek AE, Jacob HJ & RGD Team 2007 The Rat Genome Database, update 2007 - easing the path from disease to data and back again. Nucleic Acids Research 35 D658-D662. (doi:10.1093/nar/gkl988)
48. Wang XD, Vatamaniuk MZ, Wang SK, Roneker CA, Simmons RA & Lei XG 2008 Molecular mechanisms for hyperinsulinaemia induced by overproduction of selenium-dependent glutathione peroxidase-1 in mice. Diabetologia 51 1515-1524. (doi:10.1007/s00125-008-1055-3)
49. Weir GC & Bonner-Weir S 2004 Five stages of evolving b-cell dysfunction during progression to diabetes. Diabetes 53 S16-S21. (doi:10.2337/ diabetes.53.suppl_3.S16)
50. Welsh M, Nielsen DA, MacKrell AJ & Steiner DF 1985 Control of insulin gene expression in pancreatic b-cells and in an insulin-producing cell line, RIN-5F cells. II. Regulation of insulin mRNA stability. Journal of Biological Chemistry 260 13590-13594.
51. Zhang Y & Chen X 2011 Reducing selenoprotein P expression suppresses adipocyte differentiation as a result of increased preadipocyte inflammation. American Journal of Physiology. Endocrinology and Metabolism 300 E77-E85. (doi:10.1152/ajpendo.00380.2010)
52. Zhang P, Liu C, Zhang C, Zhang Y, Shen P, Zhang J & Zhang CY 2005 Free fatty acids increase PGC-1a expression in isolated rat islets. FEBS Letters 579 1446-1452. (doi:10.1016/j.febslet.2005.01.046)